CN Patent

CN106176718A — 复方卡格列净二甲双胍片

Assigned to SHANGHAI YANAN PHARM CO Ltd · Expires 2016-12-07 · 9y expired

What this patent protects

本发明涉及一种复方卡格列净二甲双胍片，包括以下重量份数的各组分：盐酸二甲双胍100份、卡格列净2‑4份、药学上可接受的辅料30‑100份；所述药学上可接受的辅料包括填充剂、崩解剂、粘合剂、碱性剂、润滑剂。本发明将卡格列净与二甲双胍结合制成复方药，通过二者的协同作用，用于治疗II型糖尿病效果更好，且无明显副反应，具有很大的应用前景。

USPTO Abstract

本发明涉及一种复方卡格列净二甲双胍片，包括以下重量份数的各组分：盐酸二甲双胍100份、卡格列净2‑4份、药学上可接受的辅料30‑100份；所述药学上可接受的辅料包括填充剂、崩解剂、粘合剂、碱性剂、润滑剂。本发明将卡格列净与二甲双胍结合制成复方药，通过二者的协同作用，用于治疗II型糖尿病效果更好，且无明显副反应，具有很大的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN106176718A
Jurisdiction
CN
Classification
—
Expires
2016-12-07
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI YANAN PHARM CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.